基本信息
views: 18
Career Trajectory
Bio
在美国 Frederick 国家癌症研究实验室,共主管,主持领导,或部分负 责了38 个生物候选药物, 2个天然候选药物的生产工艺可行性研究,工艺开发和优化,及工程放大产业化。其中,二十三个进入 GMP 生产以提供给早期临床 I/II 的研究,一个进入临床 III 期。发表SCI学术论文20多篇,专利三项。受聘国际疫苗研究所(联合国工业开发组织设立)的顾问在亚洲进行 GMP 审计及培训。此外,还曾担任数家跨国制药公司的顾问。
Research Interests
Papers共 249 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ACTA PHARMACOLOGICA SINICAno. 8 (2024): 1727-1739
Cancer communications (London, England)no. 9 (2024): 1047-1070
INTERNATIONAL IMMUNOPHARMACOLOGY (2024)
ACTA PHARMACOLOGICA SINICAno. 10 (2024): 2186-2198
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2024)
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 3 (2024)
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHno. 1 (2024)
CELL REPORTS MEDICINEno. 5 (2024)
Load More
Author Statistics
#Papers: 249
#Citation: 1752
H-Index: 23
G-Index: 36
Sociability: 6
Diversity: 4
Activity: 45
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn